Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

In order to organise coordinated research in the several sciences fundamental to the welfare and progress of the country, it was considered desirable to establish laboratories in which scientific ...

Merck Research Laboratories. "This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a step closer to helping protect adults in the EU against ...

Paula Annunziato, senior vice president, infectious diseases and vaccines, Global Clinical Development, Merck Research Laboratories, said, "Invasive pneumococcal disease can lead to serious ...

“Invasive pneumococcal disease and pneumococcal pneumonia remain critical public health challenges worldwide,” said Dr. Paula Annunziato, senior vice president, infectious diseases and vaccines, ...

Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the ...

OpenAI said Thursday that the U.S. National Laboratories will be using its latest artificial intelligence models for scientific research and nuclear weapons security. OpenAI CEO Sam Altman ...

Merck Research Laboratories. Winrevair is currently approved in 38 countries including the U.S., based on the results from the Phase 3 STELLAR study. Merck NewsMORE Related Stocks Indices ...

This event brings undergraduate research mentors and programs seeking applicants together with students seeking opportunities to learn more about available opportunities. This event is similar to a ...

Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the Phase 3 ...